These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33093777)

  • 1. Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study.
    Amlani B; Elsayed G; Barvalia U; Kanne JP; Meyer KC; Sandbo N; Li Z; McCoy SS
    Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):136-147. PubMed ID: 33093777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.
    Huapaya JA; Silhan L; Pinal-Fernandez I; Casal-Dominguez M; Johnson C; Albayda J; Paik JJ; Sanyal A; Mammen AL; Christopher-Stine L; Danoff SK
    Chest; 2019 Nov; 156(5):896-906. PubMed ID: 31238042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.
    Li X; Xu B; Ma Y; Li X; Cheng Q; Wang X; Wang G; Qian L; Wei L
    Int J Rheum Dis; 2015 May; 18(4):439-46. PubMed ID: 25925697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tofacitinib in the treatment of primary Sjögren's syndrome-associated interstitial lung disease: study protocol for a prospective, randomized, controlled and open-label trial.
    Gao R; Pu J; Wang Y; Wu Z; Liang Y; Song J; Pan S; Han F; Yang L; Xu X; Tang J; Wang X
    BMC Pulm Med; 2023 Nov; 23(1):473. PubMed ID: 38007449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab therapy in primary Sjögren's syndrome with interstitial lung disease: a retrospective cohort study.
    Chen MH; Chen CK; Chou HP; Chen MH; Tsai CY; Chang DM
    Clin Exp Rheumatol; 2016; 34(6):1077-1084. PubMed ID: 27607895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
    Adler S; Huscher D; Siegert E; Allanore Y; Czirják L; DelGaldo F; Denton CP; Distler O; Frerix M; Matucci-Cerinic M; Mueller-Ladner U; Tarner IH; Valentini G; Walker UA; Villiger PM; Riemekasten G;
    Arthritis Res Ther; 2018 Jan; 20(1):17. PubMed ID: 29382380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial lung disease in primary Sjögren's syndrome.
    Roca F; Dominique S; Schmidt J; Smail A; Duhaut P; Lévesque H; Marie I
    Autoimmun Rev; 2017 Jan; 16(1):48-54. PubMed ID: 27682894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease in Sjögren's syndrome: a clinical review.
    Luppi F; Sebastiani M; Silva M; Sverzellati N; Cavazza A; Salvarani C; Manfredi A
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):291-300. PubMed ID: 33095142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.
    Oldham JM; Lee C; Valenzi E; Witt LJ; Adegunsoye A; Hsu S; Chen L; Montner S; Chung JH; Noth I; Vij R; Strek ME
    Respir Med; 2016 Dec; 121():117-122. PubMed ID: 27888985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.
    Owen C; Ngian GS; Elford K; Moore O; Stevens W; Nikpour M; Rabusa C; Proudman S; Roddy J; Zochling J; Hill C; Sturgess A; Tymms K; Youssef P; Sahhar J
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):170-176. PubMed ID: 27049330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study.
    He SH; He YJ; Guo KJ; Liang X; Li SS; Li TF
    Clin Rheumatol; 2022 Apr; 41(4):1153-1161. PubMed ID: 34757493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
    Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases.
    Enomoto Y; Takemura T; Hagiwara E; Iwasawa T; Fukuda Y; Yanagawa N; Sakai F; Baba T; Nagaoka S; Ogura T
    PLoS One; 2013; 8(9):e73774. PubMed ID: 24040065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.
    Dong X; Zhou J; Guo X; Li Y; Xu Y; Fu Q; Lu Y; Zheng Y
    Clin Rheumatol; 2018 Nov; 37(11):2981-2988. PubMed ID: 30242640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
    Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
    Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The respiratory manifestations in patients with primary Sjögren's syndrome: is interstitial lung disease related to disease activity?
    Işık ÖÖ; Yazıcı A; Çefle A
    Turk J Med Sci; 2022 Apr; 52(5):1737-1743. PubMed ID: 36422505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients.
    Guo T; Long Y; Shen Q; Guo W; Duan W; Ouyang X; Peng H
    Ann Med; 2021 Dec; 53(1):1340-1348. PubMed ID: 34402690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAI.
    Heus A; Arends S; Van Nimwegen JF; Stel AJ; Nossent GD; Bootsma H
    Scand J Rheumatol; 2020 Jan; 49(1):38-46. PubMed ID: 31556344
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory.
    Matson SM; Baqir M; Moua T; Marll M; Kent J; Iannazzo NS; Boente RD; Donatelli JM; Dai J; Diaz FJ; Demoruelle MK; Hamblin MB; Mathai SK; Ryu JH; Pope K; Walker CM; Lee JS
    Chest; 2023 Apr; 163(4):861-869. PubMed ID: 36470416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and risk factors for primary Sjögren's syndrome combined with interstitial lung disease: a retrospective study.
    Yang Z; Zhao H; Shan L; Wang D
    Acta Biochim Pol; 2024; 71():12461. PubMed ID: 38721305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.